John L. Higgins
2008
In 2008, John L. Higgins earned a total compensation of $1.9M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,250 |
|---|---|
| Option Awards | $119,298 |
| Salary | $418,333 |
| Stock Awards | $1,131,692 |
| Other | $2,486 |
| Total | $1,860,059 |
Higgins received $1.1M in stock awards, accounting for 61% of the total pay in 2008.
Higgins also received $188.3K in non-equity incentive plan, $119.3K in option awards, $418.3K in salary and $2.5K in other compensation.
Rankings
In 2008, John L. Higgins' compensation ranked 2,630th out of 9,135 executives tracked by ExecPay. In other words, Higgins earned more than 71.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,630 out of 9,135 | 71st |
Division Manufacturing | 941 out of 3,436 | 73rd |
Major group Chemicals And Allied Products | 162 out of 815 | 80th |
Industry group Drugs | 95 out of 597 | 84th |
Industry Pharmaceutical Preparations | 73 out of 408 | 82nd |
Source: SEC filing on April 29, 2009.
Higgins' colleagues
We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2008.
2008
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
2008
Zofia Dziewanowska
Ligand Pharmaceuticals
Vice President, Clinical Research and Regulatory
2008
John Sharp
Ligand Pharmaceuticals
Chief Financial Officer
2008
Charles Berkman
Ligand Pharmaceuticals